Quest Diagnostics (DGX) Cash from Operations (2009 - 2026)

Quest Diagnostics has disclosed Cash from Operations across 18 years of filings, most recently posting 278000000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 278000000.0, down 11.46% year-over-year; the trailing twelve-month figure through Mar 2026 was 1850000000.0 (up 23.83% YoY), and the FY2025 annual result was 1886000000.0, up 41.38% from the prior year.
• Cash from Operations came in at 278000000.0 for Q1 2026 at Quest Diagnostics, down from 465000000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 563000000.0 in Q3 2025 to a low of 94000000.0 in Q1 2023.
• The 5-year median for Cash from Operations is 402000000.0 (2022), against an average of 381647058.82.
• Across the five-year window, Cash from Operations sank 80.42% in 2023 and jumped 103.9% in 2025, its largest moves.
• Quest Diagnostics' Cash from Operations stood at 334000000.0 in 2022, then soared by 57.78% to 527000000.0 in 2023, then decreased by 11.95% to 464000000.0 in 2024, then gained by 0.22% to 465000000.0 in 2025, then sank by 40.22% to 278000000.0 in 2026.
• The last three Cash from Operations figures came in at 278000000.0 (Q1 2026), 465000000.0 (Q4 2025), and 563000000.0 (Q3 2025), per Business Quant data.